Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
180.40    1.90 (1.06%)
Bid:
180.60
Ask:
181.30
Spread: 0.70 (0.388%)
Market Cap: £797.88m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Trading Update

26 Feb 2021 07:00

RNS Number : 4218Q
Pets At Home Group Plc
26 February 2021
 

 

FOR IMMEDIATE RELEASE, 26 February 2021

Pets at Home Group Plc: Trading Update 

Continued strong performance during Q4 resulting in upgrade to full-year outlook

Pets at Home Group Plc, the UK's leading pet care business, is pleased to provide an update on trading during the fourth quarter of our current financial year.

 

In our trading update on 8 January 2021, our guidance for full-year profit out-turn reflected a number of ongoing uncertainties over the near-term outlook, including renewed challenges from higher Covid infection rates and restrictions on a national level, as well as potential supply disruption relating to the UK's exit from the European Union.

 

Notwithstanding this challenging external environment, our performance over the last eight weeks has been ahead of expectations, with continued strong and broad-based growth across all channels and categories.

 

Accordingly, based on trading year to date, we now anticipate full-year underlying pre-tax profit, including the previously announced repayment of business rates relief of £28.9m, to be approximately £85m, which is ahead of our previous guidance of at least £77m1.

 

While recent positive progress around vaccinations for Covid-19 reduces the level of uncertainty ahead, our priority remains safeguarding the health, safety and wellbeing of all of our colleagues, partners and customers.

 

The Group will announce its FY21 Preliminary results on Thursday, 27 May 2021.

1. In our trading update on 8 January 2021, we anticipated FY21 Group underlying pre-tax profit on a post-IFRS16 basis, including the previously announced repayment of business rates relief of £28.9m, to be at least £77m.

 

- End of announcement -

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulations (Regulation (EU) No.596/2014). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Roger Tejwani, Director of Investor Relations & External Communication.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Roger Tejwani, Director of Investor Relations & External Communication+44 (0)1279 927022

Chris Ridgway, Head of Investor Relations+44 (0)7788 783925

Media Enquiries

Maitland/AMO: 

Clinton Manning+44 (0)7711 972662

Joanna Davidson+44 (0)7827 254567

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 451 stores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 440 First Opinion practices located both in our stores and in standalone locations. For more information visit: http://investors.petsathome.com/

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTTAMRTMTATBTB
Date   Source Headline
3rd Jun 202112:22 pmRNSDirector/PDMR Shareholding
28th May 202111:00 amRNSDirector/PDMR Shareholding
27th May 20217:20 amRNSHolding(s) in Company
27th May 20217:00 amRNSFY21 Preliminary Results
21st May 202112:25 pmRNSHolding(s) in Company
28th Apr 202112:35 pmRNSChange in Director’s details
31st Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSChange in Director's details
17th Mar 20212:22 pmRNSHolding(s) in Company
15th Mar 20214:37 pmRNSHolding(s) in Company
11th Mar 20211:36 pmRNSHolding(s) in Company
5th Mar 20213:41 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSTrading Update
1st Feb 20213:14 pmRNSHolding(s) in Company
26th Jan 20213:39 pmRNSDirector/PDMR Shareholding
26th Jan 20213:37 pmRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSTrading Statement
13th Jan 20212:04 pmRNSHolding(s) in Company
8th Jan 20217:00 amRNSTrading Update
31st Dec 202010:13 amRNSHolding(s) in Company
31st Dec 202010:04 amRNSDisposal of Specialist Group
29th Dec 20207:00 amRNSHolding(s) in Company
22nd Dec 20204:25 pmRNSDirectorate Change
18th Dec 20202:36 pmRNSDirector/PDMR Shareholding
8th Dec 20201:13 pmRNSDirectorate Change
4th Dec 20207:00 amRNSRepayment of business rates relief
1st Dec 20207:00 amRNSDisposal
30th Nov 20207:00 amRNSAcquisition
24th Nov 20207:00 amRNSFY21 Interim Results
23rd Nov 20207:00 amRNSHolding(s) in Company
18th Nov 20205:34 pmRNSHolding(s) in Company
4th Nov 20204:10 pmRNSHolding(s) in Company
2nd Nov 20204:25 pmRNSHolding(s) in Company
16th Oct 20204:18 pmRNSHolding(s) in Company
14th Oct 20207:00 amRNSHolding(s) in Company
9th Oct 20205:13 pmRNSHolding(s) in Company
8th Oct 20205:09 pmRNSHolding(s) in Company
6th Oct 20205:15 pmRNSDirector/PDMR Shareholding
6th Oct 20205:15 pmRNSDirector/PDMR Shareholding
5th Oct 20203:22 pmRNSHolding(s) in Company
2nd Oct 20204:24 pmRNSDirector/PDMR Shareholding
2nd Oct 20204:24 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSChange to Director Details
1st Oct 20204:19 pmRNSHolding(s) in Company
1st Oct 20201:04 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSAppointment of Joint Corporate Broker
28th Sep 20204:18 pmRNSHolding(s) in Company
28th Sep 202011:21 amRNSHolding(s) in Company
25th Sep 20209:14 amRNSHolding(s) in Company
24th Sep 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.